| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/02/2013 | US8475792 Molecules with extended half-lives, compositions and uses thereof |
| 07/02/2013 | US8475791 Anti-IL-TIF antibodies and methods of use |
| 07/02/2013 | US8475772 Peptide-based oral care surface reagents for personal care |
| 07/02/2013 | US8475765 Hydroxyalkyl starch derivatives |
| 07/02/2013 | CA2651583C Method and system for production of zein and/or xanthophylls using chromatography |
| 07/02/2013 | CA2622687C Methods for genetic control of insect infestations in plants and compositions thereof |
| 07/02/2013 | CA2507915C Recombinant viral-based malaria vaccines |
| 07/02/2013 | CA2505558C T cell receptor display |
| 07/02/2013 | CA2501870C Single chain recombinant t cell receptors |
| 07/02/2013 | CA2478957C Homogentisate prenyl transferase ("hpt") nucleic acids and polypeptides, and uses thereof |
| 07/02/2013 | CA2464094C Methods for ligand discovery |
| 07/02/2013 | CA2455701C The use of cross-protection to identify novel vaccine candidates for infectious agents |
| 07/02/2013 | CA2444451C Transgenic non-human animals for pharmacological and toxicological studies |
| 07/02/2013 | CA2421151C Modified vaccinia ankara virus variant |
| 07/02/2013 | CA2408302C Long wavelength engineered fluorescent proteins |
| 07/02/2013 | CA2401974C Dna expression vectors and methods of use |
| 07/02/2013 | CA2335376C Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 07/02/2013 | CA2277778C Specific pancreatic lipase inhibitors and their applications |
| 06/27/2013 | WO2013096847A1 Serum amyloid p-antibody fusion proteins |
| 06/27/2013 | WO2013096835A1 Stable protein formulations |
| 06/27/2013 | WO2013096823A1 Cationic peptides and use of such peptides for inhibiting exotoxin production |
| 06/27/2013 | WO2013096773A2 Methods, systems, and compositions for promoting recovery of peripheral neuropathy |
| 06/27/2013 | WO2013096732A2 Methods of treating or preventing viral diseases by blocking interleukin-21 |
| 06/27/2013 | WO2013096723A1 A method for hair growth using granulocyte-colony stimulating factor |
| 06/27/2013 | WO2013096315A1 Generation of engineered molecular weight standards |
| 06/27/2013 | WO2013096166A1 PSEUDOMONAS AERUGINOSA OprM EPITOPES FOR USE IN DIAGNOSTICS AND THERAPEUTICS |
| 06/27/2013 | WO2013095935A1 Compositions and methods for diagnosing and treating hyperthyroidism in companion animals |
| 06/27/2013 | WO2013095903A1 Novel gh-rh analogs with potent agonistic effects |
| 06/27/2013 | WO2013095759A1 Assessing renal structural alterations and outcomes |
| 06/27/2013 | WO2013094614A1 Method for producing synthetic amylospheroid |
| 06/27/2013 | WO2013094359A1 Cellulose-/chitin-type polymeric light-emitting material |
| 06/27/2013 | WO2013094250A1 Bifidobacterium proliferation promoter |
| 06/27/2013 | WO2013093760A2 Compositions, methods, and kits for preparing sialylated recombinant proteins |
| 06/27/2013 | WO2013093514A2 Vaccines - peptides |
| 06/27/2013 | WO2013093489A2 Detection and treatment of breast cancer |
| 06/27/2013 | WO2013093345A1 Method for detecting an infection by the hepatitis c virus |
| 06/27/2013 | WO2013093029A2 Variants of yeast ndi1 gene, and uses thereof in the treatment of disease associated with mitochondrial dysfunction |
| 06/27/2013 | WO2013093009A1 N -terminally modified insulin derivatives |
| 06/27/2013 | WO2013092953A1 Hypoallergenic allergen derivatives of pru p 3 for immunotherapy of ige-mediated peach allergy |
| 06/27/2013 | WO2013092875A1 Vaccines against hpv |
| 06/27/2013 | WO2013092840A1 Polypeptides having glucoamylase activity and method of producing the same |
| 06/27/2013 | WO2013092776A1 Novel prongf mutants and uses thereof in the production of beta-ngf |
| 06/27/2013 | WO2013092742A1 Method for patient selection |
| 06/27/2013 | WO2013092703A2 Glucagon analogues |
| 06/27/2013 | WO2013092672A2 Method for recombinant production of labyrinthopeptins and functional derivatives thereof |
| 06/27/2013 | WO2013092640A1 Optineurin-derived polypeptides, their nucleic acids and uses thereof |
| 06/27/2013 | WO2013092605A1 Hypoallergenic variants of phl p 5, the major allergen from phleum pratense |
| 06/27/2013 | WO2013092591A1 Hiv membrane fusion inhibitors |
| 06/27/2013 | WO2013092475A1 Crystals of glucokinase regulatory protein (gkrp) |
| 06/27/2013 | WO2013091924A1 Applications of an immune system-released activating agent (israa) |
| 06/27/2013 | WO2013091898A1 Method for producing high yield attenuated salmonella strains |
| 06/27/2013 | WO2013091577A1 Hybrid polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 06/27/2013 | WO2013091563A1 Methods for improving crop yield |
| 06/27/2013 | WO2013091164A1 Small molecule polypeptide for preventing and restraining inflammation and application of same |
| 06/27/2013 | WO2013091130A1 Porcine cd28 receptor, gene for coding same and application of same |
| 06/27/2013 | WO2013091089A1 Three-dimensional cavities of dendritic cell immunoreceptor (dcir), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (hiv-1) |
| 06/27/2013 | WO2013091080A1 Vesicular stomatitis virus for prime boost vaccines |
| 06/27/2013 | WO2013091070A1 Cyclic peptide mixtures from flaxseed and uses thereof |
| 06/27/2013 | WO2013091004A1 Prevention and treatment of mycobacterium infection |
| 06/27/2013 | WO2013053719A3 Regulation of receptor expression through delivery of artificial transcription factors |
| 06/27/2013 | WO2013040478A3 Hyr1-derived compositions and methods of treatment using same |
| 06/27/2013 | WO2013030620A3 Gene encoded for an mhc class i molecule, plasmid, expression system, protein, multimer, reagent and kit for analyzing a t cell frequency |
| 06/27/2013 | WO2013021284A3 Anti-il-6 vaccine composition |
| 06/27/2013 | WO2012164380A3 Dispersion and detachment of cell aggregates |
| 06/27/2013 | WO2012145814A3 Gene, mer-r anchorage cassette, mer-r expression-anchorage cassette, recombinant plasmid, transgenic bacteria line, use of said gene, use of said line in environmental bioremediation processes |
| 06/27/2013 | WO2012075549A8 Agents for increased resistance against oxidative stress conditions |
| 06/27/2013 | US20130167267 Processes using vlps with capsids resistant to hydrolases |
| 06/27/2013 | US20130167264 Pesticidal genes from brevibacillus and methods for their use |
| 06/27/2013 | US20130165970 Bonding tissues and cross-linking proteins wth naphthalimide compounds |
| 06/27/2013 | US20130165637 Use of g-csf dimer in the treatment of neutropenia |
| 06/27/2013 | US20130165635 Cloning and base sequence determination of novel iturin biosynthesis gene from antagonistic microorganism bacillus subtilis and characteristics of the gene |
| 06/27/2013 | US20130165634 Expression and export of angiogenesis inhibitors as immunofusins |
| 06/27/2013 | US20130165633 Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors |
| 06/27/2013 | US20130165626 Antifreeze protein |
| 06/27/2013 | US20130165503 Method for Treating Ocular Neovascularization |
| 06/27/2013 | US20130165391 B2-glycoprotein i peptide inhibitors |
| 06/27/2013 | US20130165389 Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same |
| 06/27/2013 | US20130165388 Method of Producing a Paralytic Peptide |
| 06/27/2013 | US20130165385 Neurogenin |
| 06/27/2013 | US20130165383 Apo-2 ligand/trail variants and uses thereof |
| 06/27/2013 | US20130165369 METHOD OF TREATING OBESITY AND METABOLIC DISORDERS RELATED TO EXCESS ADIPOSE TISSUE BY ADMINISTRATION OF sFRP-- PEPTIDE |
| 06/27/2013 | US20130165332 Compositions and methods for the treatment of immune related diseases |
| 06/27/2013 | US20130165004 Concentrated aqueous silk fibroin solution and use thereof |
| 06/27/2013 | US20130164823 Expression System |
| 06/27/2013 | US20130164817 Polypeptides having nucleic acid binding activity |
| 06/27/2013 | US20130164785 Methods and compositions for inactivating glutamine synthetase gene expression |
| 06/27/2013 | US20130164782 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 06/27/2013 | US20130164774 Methods, compositions and kits for assaying mitochondrial function |
| 06/27/2013 | US20130164766 Isolation and Application of BAD-1 For Diagnosing Infections With Blastomyces Dermatitidis |
| 06/27/2013 | US20130164749 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines |
| 06/27/2013 | US20130164733 Hepatitis-c virus testing |
| 06/27/2013 | US20130164353 Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications |
| 06/27/2013 | US20130164340 Tropoelastins and uses thereof |
| 06/27/2013 | US20130164316 Genetic signatures in hiv-1 subtype c envelope glycoproteins |
| 06/27/2013 | US20130164315 Vaccines - Screening Method |
| 06/27/2013 | US20130164313 Dna sequence, and recombinant preparation of group 4 major allergens from cereals |
| 06/27/2013 | US20130164306 Compositions and methods for treating autoimmune and inflammatory disorders |
| 06/27/2013 | US20130164298 P. gingivalis antigenic composition |
| 06/27/2013 | US20130164297 Modulation of activity of neurotrophins |
| 06/27/2013 | US20130164289 Human cytomegalovirus vaccine |